Back to Journals » OncoTargets and Therapy » Volume 11

Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung

Total article views   HTML views PDF downloads Totals
9,288 Dovepress* 8,623+ 871 9,494
PubMed Central* 665 234 899
Totals 9,288 1,105 10,393
*Since 30 November 2018
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar